+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infectious Enteritis Treatment Market 2019-2025

  • PDF Icon


  • May 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 5129916
Global Infectious Enteritis Treatment Market Size, Share & Trends Analysis Report, by Type (Antibiotics, Antiviral, and Other), by Route of Administration (Oral and Injectable) and Forecast Period, 2019-2025.

The global infectious enteritis treatment market is estimated to grow significantly during the forecast period. The market is boosting due to several factors including the high incidence of this infectious disease in children. According to WHO, around 1.7 billion cases of infectious enteritis is diagnosed majorly in children every year. This increase in the incidence of these infectious enteritis leads to an increase in the growth of the infectious enteritis treatment market. Commonly used drugs in infectious enteritis treatment such as Chloramphenicol and tetracycline are boosting the market growth.

The global infectious enteritis treatment market is segmented based on the type and route of administration. Based on type, the market is classified into antibiotics, antiviral, and Other. Based on the route of administration, the market is classified into oral and injectable. Geographically, the global infectious enteritis treatment market is classified into North America, Europe, Asia-Pacific, and the Rest of the world.

North America is estimated to witness significant growth in the market and is expected to retain its dominance in the coming years. North America has engaged with considerable participation in the market owing to the presence of major companies, such as Abbott Laboratories, Pfizer, Inc., and Bristol Myers Squibb Co. These are the major companies in the infectious enteritis treatment market, which focuses on offering innovative infectious treatment drugs. Apart from this, an increase in technological availability leads the companies to do intensive R&D to expand the therapeutic application.

The major companies operating in the market include Abbott Laboratories, Pfizer, Inc., Bristol-Myers Squibb Co., AstraZeneca PLC, F. Hoffmann-La Roche AG, GlaxoSmithKline, PLC, Novartis AG, and Teva Pharmaceuticals Industries, Ltd.

Research Methodology

The market study of the global infectious enteritis treatment market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for drug manufactures companies, research institutes, and government agencies for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Infectious Enteritis Treatment Market Research and Analysis by Type
  • Global Infectious Enteritis Treatment Market Research and Analysis by Route of Administration

The Report covers:
  • Comprehensive research methodologies of the global infectious enteritis treatment market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global infectious enteritis treatment market.
  • Insights about market determinants which are stimulating the global infectious enteritis treatment market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Pfizer, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Abbott Laboratories Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. Bristol-Myers Squibb Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. GlaxoSmithKline, PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. F. Hoffmann-La Roche AG Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Infectious Enteritis Treatment Market by Type
5.1.1. Antibiotics
5.1.2. Antiviral
5.1.3. Other (Intravenous (IV) Fluids)
5.2. Global Infectious Enteritis Treatment Market by Route of Administration
5.2.1. Oral
5.2.2. Injectable
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories
7.2. Actelion Pharmaceuticals, Ltd.
7.3. Apotex, Inc.
7.4. Aqua Pharmaceuticals, LLC
7.5. AstraZeneca PLC
7.6. BioGaia AB
7.7. Bristol-Myers Squibb Co.
7.8. F. Hoffmann-La Roche AG
7.9. GlaxoSmithKline, PLC
7.10. Lonza AG
7.11. Mylan N.V.
7.12. Novartis AG
7.13. Pfizer, Inc.
7.14. Teva Pharmaceuticals Industries, Ltd.
7.15. Valeant Pharmaceuticals International, Inc.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Actelion Pharmaceuticals, Ltd.
  • Apotex, Inc.
  • Aqua Pharmaceuticals, LLC
  • AstraZeneca PLC
  • BioGaia AB
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline, PLC
  • Lonza AG
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries, Ltd.
  • Valeant Pharmaceuticals International, Inc.